CD64 index and triggering receptor expressed on myeloid cells-1 are biomarkers on neutrophil polymorphonuclear cells with crucial role in sepsis. The study aim is to assess diagnostic performance, individually and combined, of CD64 index and triggering receptor expressed on myeloid cells-1 (surface marker/soluble form), in late-onset sepsis of preterm infants
A total of 338 infants with suspected clinical sepsis were investigated, 115 of whom were found to b...
Background Despite major advances in the management of newborn infants, neonatal sepsis (NS) remain ...
Background. Neonatal sepsis (NS) is a very critical medical situation associated with high morbiditi...
Neutrophil CD64 has been proposed as an early marker of sepsis. This study aims to evaluate the diag...
Neutrophil CD64 has been proposed as an early marker of sepsis. This study aims to evaluate the diag...
The role of CD64 in late onset sepsis (LOS) in preterm infants has been described in several studies...
<div><p>Introduction</p><p>The role of CD64 in late onset sepsis (LOS) in preterm infants has been d...
Objective Sepsis is a complex clinical condition caused by a dysregulated immune response to an infe...
BackgroundNeonatal sepsis is an important cause of neonatal morbidity and mortality in the neonatal ...
Differential diagnosis between sepsis and non-infectious inflammatory disorders demands improved bio...
Background: Neonatal sepsis is a life-threatening disease with an incidence of 1 to 10 per 1000 live...
Background: Research into new markers has been intensified for early diagnosis, prognosis, and diffe...
Objective: To assess the diagnostic and prognostic utility of CD64 expression as a marker of early-o...
BACKGROUND: Early detection and treatment of infected preterm infants could decrease morbidity and m...
Objective. To evaluate the expression of CD64 and CD163 on neutrophils and monocytes in SIRS with/wi...
A total of 338 infants with suspected clinical sepsis were investigated, 115 of whom were found to b...
Background Despite major advances in the management of newborn infants, neonatal sepsis (NS) remain ...
Background. Neonatal sepsis (NS) is a very critical medical situation associated with high morbiditi...
Neutrophil CD64 has been proposed as an early marker of sepsis. This study aims to evaluate the diag...
Neutrophil CD64 has been proposed as an early marker of sepsis. This study aims to evaluate the diag...
The role of CD64 in late onset sepsis (LOS) in preterm infants has been described in several studies...
<div><p>Introduction</p><p>The role of CD64 in late onset sepsis (LOS) in preterm infants has been d...
Objective Sepsis is a complex clinical condition caused by a dysregulated immune response to an infe...
BackgroundNeonatal sepsis is an important cause of neonatal morbidity and mortality in the neonatal ...
Differential diagnosis between sepsis and non-infectious inflammatory disorders demands improved bio...
Background: Neonatal sepsis is a life-threatening disease with an incidence of 1 to 10 per 1000 live...
Background: Research into new markers has been intensified for early diagnosis, prognosis, and diffe...
Objective: To assess the diagnostic and prognostic utility of CD64 expression as a marker of early-o...
BACKGROUND: Early detection and treatment of infected preterm infants could decrease morbidity and m...
Objective. To evaluate the expression of CD64 and CD163 on neutrophils and monocytes in SIRS with/wi...
A total of 338 infants with suspected clinical sepsis were investigated, 115 of whom were found to b...
Background Despite major advances in the management of newborn infants, neonatal sepsis (NS) remain ...
Background. Neonatal sepsis (NS) is a very critical medical situation associated with high morbiditi...